Viewing Study NCT05522556


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-04-17 @ 1:21 PM
Study NCT ID: NCT05522556
Status: AVAILABLE
Last Update Posted: 2025-11-18
First Post: 2022-08-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module